155 related articles for article (PubMed ID: 10561619)
1. The cost-effectiveness of voluntary intrapartum rapid human immunodeficiency virus testing for women without adequate prenatal care.
Grobman WA; Garcia PM
Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 1):1062-71. PubMed ID: 10561619
[TBL] [Abstract][Full Text] [Related]
2. Economic impact of treatment of HIV-positive pregnant women and their newborns with zidovudine. Implications for HIV screening.
Mauskopf JA; Paul JE; Wichman DS; White AD; Tilson HH
JAMA; 1996 Jul; 276(2):132-8. PubMed ID: 8656505
[TBL] [Abstract][Full Text] [Related]
3. Rapid testing and zidovudine treatment to prevent vertical transmission of human immunodeficiency virus in unregistered parturients: a cost-effectiveness analysis.
Stringer JS; Rouse DJ
Obstet Gynecol; 1999 Jul; 94(1):34-40. PubMed ID: 10389714
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of interventions to reduce vertical HIV transmission from pregnant women who have not received prenatal care.
Mrus JM; Tsevat J
Med Decis Making; 2004; 24(1):30-9. PubMed ID: 15005952
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of universal compared with voluntary screening for human immunodeficiency virus among pregnant women in Chicago.
Immergluck LC; Cull WL; Schwartz A; Elstein AS
Pediatrics; 2000 Apr; 105(4):E54. PubMed ID: 10742375
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of mandatory compared with voluntary screening for human immunodeficiency virus in pregnancy.
Myers ER; Thompson JW; Simpson K
Obstet Gynecol; 1998 Feb; 91(2):174-81. PubMed ID: 9469271
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of short-course zidovudine to prevent perinatal HIV type 1 infection in a sub-Saharan African Developing country setting.
Mansergh G; Haddix AC; Steketee RW; Nieburg PI; Hu DJ; Simonds RJ; Rogers M
JAMA; 1996 Jul; 276(2):139-45. PubMed ID: 8656506
[TBL] [Abstract][Full Text] [Related]
8. Rapid HIV versus enzyme-linked immunosorbent assay screening in a low-risk Mexican American population presenting in labor: a cost-effectiveness analysis.
Doyle NM; Levison JE; Gardner MO
Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1280-5. PubMed ID: 16157152
[TBL] [Abstract][Full Text] [Related]
9. Preventing perinatal transmission of HIV--costs and effectiveness of a recommended intervention.
Gorsky RD; Farnham PG; Straus WL; Caldwell B; Holtgrave DR; Simonds RJ; Rogers MF; Guinan ME
Public Health Rep; 1996; 111(4):335-41. PubMed ID: 8711101
[TBL] [Abstract][Full Text] [Related]
10. A decision analysis of mandatory compared with voluntary HIV testing in pregnant women.
Nakchbandi IA; Longenecker JC; Ricksecker MA; Latta RA; Healton C; Smith DG
Ann Intern Med; 1998 May; 128(9):760-7. PubMed ID: 9556471
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of HIV screening for incarcerated pregnant women.
Resch S; Altice FL; Paltiel AD
J Acquir Immune Defic Syndr; 2005 Feb; 38(2):163-73. PubMed ID: 15671801
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of antiviral drug therapy to reduce mother-to-child HIV transmission in sub-Saharan Africa.
Marseille E; Kahn JG; Saba J
AIDS; 1998 May; 12(8):939-48. PubMed ID: 9631148
[TBL] [Abstract][Full Text] [Related]
13. Incremental cost-effectiveness of two zidovudine regimens to prevent perinatal HIV transmission in the United States.
Pinkerton SD; Holtgrave DR; Layde PM
Prev Med; 2000 Jan; 30(1):64-9. PubMed ID: 10642461
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of strategies to reduce mother-to-child HIV transmission in Mexico, a low-prevalence setting.
Rely K; Bertozzi SM; Avila-Figueroa C; Guijarro MT
Health Policy Plan; 2003 Sep; 18(3):290-8. PubMed ID: 12917270
[TBL] [Abstract][Full Text] [Related]
15. Universal antenatal human immunodeficiency virus (HIV) testing programme is cost-effective despite a low HIV prevalence in Hong Kong.
Lee PM; Wong KH
Hong Kong Med J; 2007 Jun; 13(3):199-207. PubMed ID: 17548908
[TBL] [Abstract][Full Text] [Related]
16. [A comparison of three screening strategies for prevention of perinatal HIV infection in Colombia: a decision analysis model].
Gómez M
Rev Panam Salud Publica; 2008 Oct; 24(4):256-64. PubMed ID: 19133174
[TBL] [Abstract][Full Text] [Related]
17. Universal HIV screening of pregnant women in England: cost effectiveness analysis.
Postma MJ; Beck EJ; Mandalia S; Sherr L; Walters MD; Houweling H; Jager JC
BMJ; 1999 Jun; 318(7199):1656-60. PubMed ID: 10373167
[TBL] [Abstract][Full Text] [Related]
18. The cost-effectiveness of human immunodeficiency virus screening in pregnancy.
Ecker JL
Am J Obstet Gynecol; 1996 Feb; 174(2):716-21. PubMed ID: 8623812
[TBL] [Abstract][Full Text] [Related]
19. Missed opportunities for perinatal HIV prevention among HIV-exposed infants born 1996-2000, pediatric spectrum of HIV disease cohort.
Peters V; Liu KL; Dominguez K; Frederick T; Melville S; Hsu HW; Ortiz I; Rakusan T; Gill B; Thomas P
Pediatrics; 2003 May; 111(5 Pt 2):1186-91. PubMed ID: 12728136
[TBL] [Abstract][Full Text] [Related]
20. Point-of-care HIV viral load in pregnant women without prenatal care: a cost-effectiveness analysis.
Avram CM; Greiner KS; Tilden E; Caughey AB
Am J Obstet Gynecol; 2019 Sep; 221(3):265.e1-265.e9. PubMed ID: 31229430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
